Biosimilars - Regulatory Framework and Pipeline Analysis

Posted June 19, 2015 by sonalimrr

The Report Biosimilars - Regulatory Framework and Pipeline Analysis provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. -

Biosimilars are copied versions of biologics that offer a 20-50% reduction in cost compared with innovative biologic products. Biosimilars are getting the world wide attention as the cost of the innovative biologics are enormously high and even minimal reduction in price will reduce the healthcare spending substantially. All the countries are focusing on reducing the healthcare expenditure and biosimilars compliments to this goal. Biologic products are complex in structure and follow a complex manufacturing process thus, some variation exists between the reference product and its biosimilar. It is very important to assess the variations in biosimilars by comparing with reference product to ensure quality, non-clinical, and clinical properties, which has given rise to the regulatory requirements for biosimilars. Regulatory requirement for approving biosimilars varies across different regulatory bodies. However, all the countries have derived the basic theme from EMA and WHO guidelines for framing their regulatory structure. There is a need to harmonize the nomenclature of biosimilars, extrapolation of indications, and interchangeability of biosimilars with reference products across the regulatory bodies. Biosimilars market is developing and it could be well established with the pipeline that is poised to deliver a wave of biosimilars in the market in the near future

View Full Report at


The scope of the report includes:

Market dynamics: Trends, Drivers, and Barriers
WHO guidance for biosimilars
Regulatory overview, biosimilar guidelines, regulatory framework for biosimilars, and market outlook for:
South Korea
Key players
Pipeline Analysis
By Stage of Development / Molecule / Therapy Area / Indication
Late-Stage / Phase II / Phase I Pipeline Biosimilars

Download Sample Copy of this Report at

Reasons To Buy

The report will enhance your decision-making capability by allowing you to:

Understand the regulatory requirement and regulatory framework that facilitates effective product development strategy as biosimilars industry is currently highly focused, growing, and outpacing the growth rate of small molecule pharmaceutical market
Targeting geographies would be easy by comparing different regulatory frameworks; this would also provide a base for designing a strategy to enter the developed markets. Biosimilars are of interest in developed countries to reduce the healthcare expenditure
With the recent approvals of biosimilars by USFDA, the biosimilars market is going to grow and this report examines the post approval market landscape
Examine the biosimilars pipeline and specifies the products that are highly targeted, it also includes analysis of highly focused indications, mechanism of actions, and therapy areas in the pipeline
Analyze the details of the clinical pipeline that includes late stage products, Phase II, and Phase I products. Detailed understanding of the pipeline will help in targeting the products for development, rate the current products and predict the competition

Table of Contents

Executive Summary
Biosimilars Industry Dynamics
Biosimilars Regulation: WHO's Guidance
Biosimilars in Europe
Regulatory Framework
Market Outlook
Biosimilars in the US
Regulatory Framework
Market Outlook
Biosimilars in India
Regulatory Framework
Market Outlook
Biosimilars in South Korea
Regulatory Framework
Market Outlook
Biosimilars in Japan

About ( is the most comprehensive collection of market research reports, supporting clients’ market intelligence needs with over 100,000 market research reports, company profiles, data books, and regional market profits in its repository. We also offer consulting support for custom market research needs.Our document database is updated by the hour, which means that our customers always have access to fresh data spanning over 300 industries. From Fortune 500 companies to SMEs, has built a veritable reputation for fulfilling the most exacting market research needs.

Read our latest articles at


Toll Free: 866-997-4948

Tel: +1-518-618-1030
E: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By
Phone +1-518-618-1030
Business Address 90 Sate Street, Suite 700 Albany, NY 12207
Country United Kingdom
Categories Medical
Tags biosimilars , market research reports , Trends , Forecasts
Last Updated June 19, 2015